본문 바로가기
메인메뉴
Company
About Qurient
History
Management
Contact Us
Business Philosophy
Business Philosophy
Pipeline
Pipeline
Q702
Q301
TELACEBEC(Q203)
5-Lipoxygenase Inhibitor
Selective CDK7 Inhibitor
IR / PR
Notice
Press Release
Stock Information
Financial
Disclosure
홈페이지로 바로가기
Company
Business Philosophy
Pipeline
IR / PR
Notice
Press Release
Stock Information
Financial
Disclosure
Notice
게시물 검색
검색대상
title
contents
title+contents
검색어
필수
Notice 목록
Num.
Title
Author
Date
Views
1
Dear Qurient shareholders
Qurient
03-19
106
열린
1
페이지
information for download file
Name
Company
Phone
Business e-mail
Comment
Request Download
팝업 닫기
